Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-02-09 Sale | 2024-02-09 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 96,950 | $10.92 | $1,058,694 | 13,058,441 (Direct) | View |
2024-01-02 Sale | 2024-01-03 4:56 pm | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 3,000,000 | $11.05 | $33,150,000 | 51,929,426 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-20 Tax Withholding | 2024-03-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 16,003 | $10.01 | 500,202 (Direct) | View |
2024-03-20 Tax Withholding | 2024-03-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,506 | $10.01 | 187,769 (Direct) | View |
2024-03-20 Tax Withholding | 2024-03-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $10.01 | 990,063 (Direct) | View |
2024-03-07 Other | 2024-03-07 6:35 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 30,257,723 | $0 | 34,784,621 (Indirect) | View |
2024-03-07 Other | 2024-03-07 6:09 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 45,821,757 | $0 | 78,858,646 (Indirect) | View |
2024-03-07 Other | 2024-03-07 5:53 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director 10% Owner | 45,821,757 | $0 | 48,584,883 (Indirect) | View |
2024-02-28 Tax Withholding | 2024-03-01 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,630 | $11.71 | 269,553 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,508 | $11.54 | 189,275 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 16,002 | $11.54 | 516,205 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $11.54 | 1,001,008 (Direct) | View |
2024-02-09 Exercise | 2024-02-09 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 96,950 | $0 | 13,058,441 (Direct) | View |
2024-02-09 Exercise | 2024-02-09 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 96,950 | $3.85 | 13,058,441 (Direct) | View |
2024-01-28 Tax Withholding | 2024-01-30 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,896 | $10.37 | 271,183 (Direct) | View |
2024-01-19 Option Award | 2024-01-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 1,570 | $0 | 76,339 (Direct) | View |
2024-01-19 Option Award | 2024-01-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 1,328 | $0 | 12,686 (Direct) | View |
2024-01-19 Option Award | 2024-01-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 1,207 | $0 | 21,538 (Direct) | View |
2024-01-20 Tax Withholding | 2024-01-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,506 | $10.35 | 190,783 (Direct) | View |
2024-01-19 Option Award | 2024-01-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 3,366 | $0 | 78,342 (Direct) | View |
2024-01-20 Tax Withholding | 2024-01-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $10.35 | 1,011,953 (Direct) | View |
2024-01-20 Tax Withholding | 2024-01-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 12,377 | $10.35 | 532,207 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 611,393 | $6.4 | 73,633,116 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 275,227 | $0 | 73,633,116 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 251,538 | $11.5 | 73,633,116 (Direct) | View |
2023-12-27 Tax Withholding | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 133,911 | $11.58 | 73,633,116 (Direct) | View |
2023-12-28 Tax Withholding | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,913 | $11.37 | 273,079 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 85,232 | $6.4 | 4,195,421 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 38,453 | $0 | 4,195,421 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 47,351 | $11.5 | 4,195,421 (Direct) | View |
2023-12-27 Tax Withholding | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 22,043 | $11.58 | 4,195,421 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 159,100 | $6.4 | 8,109,865 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 71,365 | $0 | 8,109,865 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 28,411 | $11.5 | 8,109,865 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 13 | $0 | 279,415 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,894 | $11.5 | 279,415 (Direct) | View |
2023-12-27 Tax Withholding | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 6 | $11.58 | 279,415 (Direct) | View |
2023-12-20 Tax Withholding | 2023-12-22 7:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 16,003 | $9.96 | 544,584 (Direct) | View |
2023-12-20 Tax Withholding | 2023-12-22 7:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $9.96 | 1,006,488 (Direct) | View |
2023-12-20 Tax Withholding | 2023-12-22 7:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,364 | $9.96 | 192,282 (Direct) | View |
2023-11-29 Other | 2023-12-01 9:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,360 | $9.13 | 277,282 (Direct) | View |
2023-11-22 Other | 2023-11-27 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 16,549 | $8.68 | 577,136 (Direct) | View |
2023-11-22 Other | 2023-11-27 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,415 | $8.68 | 195,061 (Direct) | View |
2023-11-22 Other | 2023-11-27 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 11,318 | $8.68 | 1,028,751 (Direct) | View |
2023-10-30 Other | 2023-11-01 9:39 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,360 | $8.39 | 279,712 (Direct) | View |
2023-10-24 Other | 2023-10-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 18,261 | $8.99 | 595,397 (Direct) | View |
2023-10-24 Other | 2023-10-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 12,489 | $8.99 | 1,041,240 (Direct) | View |
2023-10-24 Other | 2023-10-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,563 | $8.99 | 196,624 (Direct) | View |
2022-10-16 Option Award | 2023-10-18 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 1,594 | $0 | 75,456 (Direct) | View |
2023-10-17 Other | 2023-10-18 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 687 | $10.3 | 75,456 (Direct) | View |
2023-10-16 Option Award | 2023-10-18 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 2,269 | $0 | 74,976 (Direct) | View |
2023-10-16 Option Award | 2023-10-18 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 1,226 | $0 | 20,331 (Direct) | View |
2023-10-16 Option Award | 2023-10-18 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 1,269 | $0 | 11,358 (Direct) | View |